ArticleCureus2025
Barriers to Utilizing Breast Cancer Screening Methods Among Adult Females in Taif, Saudi Arabia: A Cross-Sectional Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Breast cancer (BC) is one of the leading causes of cancer-related deaths worldwide. Screening methods for early detection have significantly reduced mortality rates and improved survival rates associated with this disease. The study presented in this paper aimed to identify the barriers to regular breast cancer screening methods for early detection among adult females in Taif City. Objectives This analytical cross-sectional study sought to identify the most prevalent barriers to the use of various breast cancer screening methods. Methods A cross-sectional study was conducted between January 2024 and November 2024. A validated and pretested questionnaire was utilized for data collection after identifying the participants, who were women aged 18 years and older, residing in Taif City. An online questionnaire was sent out to these 405 females. The questionnaire comprised questions on the participants' socio-demographic details, breast cancer-related background, and screening-related aspects that covered personal experiences, including those related to routine clinical breast examinations (CBEs), breast self-examinations (BSEs), and mammography. Pertinent questions-drawing on the modified champion health beliefs model scale (CHBMS)-were also included. Results Of the 405 women respondents from Taif, 4.7% reported undergoing mammography regularly, 7.9% indicated they undergo CBE regularly, and 25.7% stated they perform BSE regularly. The most commonly reported warning sign of breast cancer among participants was pain in one breast or axilla, noted by 73.3%. The most frequently identified risk factors were a previous history of breast cancer (67.7%) and having a close relative who was diagnosed with breast cancer (63.3%). The primary barrier to BSE was difficulty remembering to perform the examination, reported by 42.2% of participants. Conversely, the main barrier to CBE was embarrassment, cited by 37.3% of participants. The primary barriers preventing women from undergoing mammography were embarrassment (30.4%) and pain (17.8%). Conclusion Participants demonstrated a high level of awareness regarding breast cancer symptoms and risk factors; however, overall screening rates remain low. The study revealed several barriers preventing women from undergoing screening, including anxiety about BSE and some feeling embarrassed as regards CBE. There is, thus, an urgent need for a comprehensive approach to educate women about the importance of breast cancer screening. Educational programs to enhance awareness and encourage early detection are the need of the hour.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.